Operationalizing International Regulatory Standards in a Limited-Resource Setting during an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience

3Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

International regulatory standards ensure human subjects protection, data quality, and scientific integrity of clinical trials. Operationalizing regulatory standards during a large vaccine clinical trial - the Sierra Leone Trial to Introduce a Vaccine Against Ebola - in a resource-constrained setting during an epidemic required flexibility and creativity. We highlight areas that required special attention, such as developing standard operating procedures appropriate for the setting, obtaining space and supplies for the regulatory office, and creating a strategy to maintain both a dedicated central regulatory office and satellite regulatory sites for this trial with paper-based records.

Cite

CITATION STYLE

APA

Kabineh, A. K., Carr, W., Motevalli, M., Legardy-Williams, J., Vincent, W., Mahon, B. E., & Samai, M. (2018). Operationalizing International Regulatory Standards in a Limited-Resource Setting during an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience. Journal of Infectious Diseases, 217, S56–S59. https://doi.org/10.1093/infdis/jiy111

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free